Skip to main content

No results found

Please try a different search

Featured

Techniques & Methods

Articles  -  24 April 2026

The early DART blind spot: Why developmental toxicity needs a rethink in 2026

View all content

Flow Cytometry

Articles  —  20 August Aug 2024

Cell and Gene Therapy Answers: The critical role of flow cytometry in adoptive cell therapies

Read More about Cell and Gene Therapy Answers: The critical role of flow cytometry in adoptive cell therapies
Articles  —  14 December Dec 2023

Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation

Read More about Minimal Residual Disease by Flow Cytometry: Latest Insights on Validation
Articles  —  21 November Nov 2022

Eight instrument considerations in flow cytometry

Read More about Eight instrument considerations in flow cytometry
View all content

ELISA

Articles  —  6 December Dec 2023

Identification and quantification of host cell proteins in biopharmaceutical products

Read More about Identification and quantification of host cell proteins in biopharmaceutical products
View all content

LC-MS

Articles  —  16 July Jul 2025

Molecular bioanalysis considerations along the drug development journey

Read More about Molecular bioanalysis considerations along the drug development journey
Articles  —  6 December Dec 2023

Identification and quantification of host cell proteins in biopharmaceutical products

Read More about Identification and quantification of host cell proteins in biopharmaceutical products
View all content

QSARs

Articles  -  20 August 2021

Quantitative Structure Activity Relationships (QSAR) in Toxicity Testing

View all content

NAMs: New Approach Methods

Articles  -  24 April 2026

The early DART blind spot: Why developmental toxicity needs a rethink in 2026

Articles  -  24 April 2026

Inside preclinical NAMs innovation: A Q&A with Labcorp experts Darren Kidd and Jessica Palmer on devTOX quickPredict™

Articles  -  16 January 2026

From policy to practice: How Labcorp’s new approach methods align with the U.K.’s new safety testing strategy

View all content